Services of MTRC

The appointment of Mr. Vasileios Kontogiannis marks an important step in strengthening MTRC’s Health Economics capabilities. He brings over six years of experience from recognized consultancies including Symmetron, IQVIA and OptimaxAccess. Vasileios has a deep insight into NHS function through his experience as a Programme Manager at the UK's National Institute for Health Research. His academic background includes a research role at Newcastle University and authorship of over 12 peer-reviewed publications. His background enhances MTRC’s ability to deliver robust HTA and reimbursement support across diverse healthcare systems.

MTRC is pleased to announce that Markus Siebert, Founder of Metis Market Access, has joined forces with the company as Strategic Advisor. Markus brings more than 25 years of international leadership experience in reimbursement, health economics, and market access strategy across Europe and Asia-Pacific. Prior to launching Metis Market Access, Markus spent nearly nine years at Abbott as Senior Director Reimbursement & Healthcare Economics International, where he led reimbursement strategies and health economic evidence development across EMEA, Asia, and Australia.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of February 23rd, we plan to work on 16 projects. Review the complete list of planned activities in this post.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of February 09th, we plan to work on 17 projects. Review the complete list of planned activities in this post.

Ms. Giselle Balaciano joins MTRC as Evidence Synthesis Specialist, bringing nearly 20 years of expertise in HTA, clinical guideline development, and systematic reviews. As Methodology Advisor to the Argentinian Ministry of Health and trainer with Cochrane Argentina, she has shaped national healthcare policies and contributed to over 100 HTA and evidence synthesis projects published in leading scientific journals. Her appointment significantly enhances MTRC’s ability to deliver high-impact, decision-ready evidence for market access and policy-making. This strengthens MTRC’s role as a trusted partner in advancing evidence-based healthcare decisions across global markets.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of January 26th, we plan to work on 12 projects. Review the complete list of planned activities in this post.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of December 15th, we plan to work on 19 projects. Review the complete list of planned activities in this post.

MTRC has released a White Paper titled "Health Technology Assessment 2015-2024 Trends in Europe". The White Paper is focused on providing a brief description of the health technology assessment (HTA) framework for medical technologies in individual European countries and showcasing trends in Med Tech HTA in individual EU countries.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of December 1st, we plan to work on 23 projects. Review the complete list of planned activities in this post.

MTRC announces the launch of its free Market Access Training Program, supporting professionals new to the European MedTech landscape. The first cohort begins on 15 January 2026, featuring an integrated curriculum of webinars, recorded sessions, and expert-guided practical application.

MTRC invites market access professionals from MedTech, IVD, and digital health companies to participate in a short online survey exploring how industry experts stay informed about developments in market access.

Our goal at MTRC is to inform the decision-making of our clients and to support their market access activities. Below is a snapshot of our planned activities for the next two weeks. This can help our existing and prospective clients understand the potential scope of our support better. From the week of November 17th, we plan to work on 22 projects. Review the complete list of planned activities in this post.